GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (SHSE:601607) » Definitions » Cyclically Adjusted Revenue per Share

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Cyclically Adjusted Revenue per Share : ¥61.32 (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Shanghai Pharmaceuticals Holding Co's adjusted revenue per share for the three months ended in Mar. 2024 was ¥19.104. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥61.32 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Shanghai Pharmaceuticals Holding Co's average Cyclically Adjusted Revenue Growth Rate was 5.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.70% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Shanghai Pharmaceuticals Holding Co was 13.00% per year. The lowest was 0.70% per year. And the median was 5.35% per year.

As of today (2024-05-06), Shanghai Pharmaceuticals Holding Co's current stock price is ¥18.10. Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥61.32. Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio of today is 0.30.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shanghai Pharmaceuticals Holding Co was 1.05. The lowest was 0.26. And the median was 0.47.


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Cyclically Adjusted Revenue per Share Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.43 46.85 52.34 56.96 60.33

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.88 58.57 59.87 60.33 61.32

Competitive Comparison of Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Revenue per Share

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio falls into.



Shanghai Pharmaceuticals Holding Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shanghai Pharmaceuticals Holding Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=19.104/114.6694*114.6694
=19.104

Current CPI (Mar. 2024) = 114.6694.

Shanghai Pharmaceuticals Holding Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 8.458 98.200 9.877
201409 9.186 98.900 10.651
201412 8.806 99.000 10.200
201503 9.344 99.900 10.725
201506 9.604 99.500 11.068
201509 10.447 100.500 11.920
201512 9.845 100.600 11.222
201603 10.889 102.200 12.218
201606 11.312 101.400 12.792
201609 11.462 102.400 12.835
201612 11.248 102.600 12.571
201703 12.322 103.200 13.691
201706 12.140 103.100 13.502
201709 12.365 104.100 13.620
201712 11.831 104.500 12.982
201803 13.038 105.300 14.198
201806 13.894 104.900 15.188
201809 14.768 106.600 15.886
201812 14.521 106.500 15.635
201903 16.338 107.700 17.395
201906 16.058 107.700 17.097
201909 16.840 109.800 17.587
201912 16.187 111.200 16.692
202003 14.417 112.300 14.721
202006 16.247 110.400 16.875
202009 18.802 111.700 19.302
202012 17.948 111.500 18.458
202103 18.253 112.662 18.578
202106 18.911 111.769 19.402
202109 19.548 112.215 19.975
202112 19.127 113.108 19.391
202203 20.012 114.335 20.071
202206 14.823 114.558 14.837
202209 18.399 115.339 18.292
202212 14.357 115.116 14.301
202303 17.891 115.116 17.822
202306 18.182 114.558 18.200
202309 17.512 115.339 17.410
202312 16.888 114.669 16.888
202403 19.104 114.669 19.104

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Shanghai Pharmaceuticals Holding Co  (SHSE:601607) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=18.10/61.32
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shanghai Pharmaceuticals Holding Co was 1.05. The lowest was 0.26. And the median was 0.47.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Shanghai Pharmaceuticals Holding Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Pharmaceuticals Holding Co (SHSE:601607) Business Description

Traded in Other Exchanges
Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Headlines

No Headlines